MiMedx Group, Inc.
MDXG
$4.36
-$0.05-1.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.30% | 74.17% | 36.92% | -5.58% | -8.12% |
| Total Depreciation and Amortization | -39.13% | 68.26% | -2.57% | 7.93% | 158.87% |
| Total Amortization of Deferred Charges | -- | -- | -200.00% | -- | -- |
| Total Other Non-Cash Items | -37.54% | 121.96% | 0.84% | -25.08% | 14.17% |
| Change in Net Operating Assets | 70.71% | -43.08% | 61.95% | -2,681.97% | -87.55% |
| Cash from Operations | -14.91% | 103.41% | 172.11% | -71.79% | -4.29% |
| Capital Expenditure | -48.44% | -7.26% | 52.52% | -43.35% | -53.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -337.71% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.50% | -24,925.00% | 72.41% | -262.50% | -102.82% |
| Cash from Investing | 93.63% | -492.78% | -118.47% | 85.33% | -2,548.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | -7.76% | 7.57% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 38.55% | 84.22% | 78.60% | -7,829.03% | 71.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.18% | -7.38% | -- | -- | -- |
| Cash from Financing | 31.97% | 21.66% | 61.99% | -619.50% | -1,581.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.55% | 86.64% | 517.27% | -87.10% | -20.99% |